LIVE
OpenAI Partners with Chilean Ministry to Advance Public Sector AI Ambience Healthcare Expands Clinical AI Suite for Hospital Operations AI Models Vulnerable to Manipulation in Simulated Warfare Scenarios, Research Shows AWS Highlights Enterprise Governance and AI Workspace Quick Ahead of re:Invent 2026 LoanPro Integrates Amazon Bedrock to Automate Loan Servicing Workflows Google Brings Wallet App to iOS Users Across the United States Microsoft Reveals Cause of Global Outlook Outage AWS Outlines Phased Roadmap for Responsible Agentic AI Governance Google updates Gemini settings to separate chat history from AI model training Uber Eats and Zipline launch autonomous drone food delivery in Houston OpenAI Partners with Chilean Ministry to Advance Public Sector AI Ambience Healthcare Expands Clinical AI Suite for Hospital Operations AI Models Vulnerable to Manipulation in Simulated Warfare Scenarios, Research Shows AWS Highlights Enterprise Governance and AI Workspace Quick Ahead of re:Invent 2026 LoanPro Integrates Amazon Bedrock to Automate Loan Servicing Workflows Google Brings Wallet App to iOS Users Across the United States Microsoft Reveals Cause of Global Outlook Outage AWS Outlines Phased Roadmap for Responsible Agentic AI Governance Google updates Gemini settings to separate chat history from AI model training Uber Eats and Zipline launch autonomous drone food delivery in Houston

Eli Lilly CEO and Experts Criticize Anthropic Chief Over Medical Claims

🚀 Startups & Funding 1 min read 👁 5

Eli Lilly CEO Dave Ricks and various experts have pushed back against bold medical predictions made by Anthropic CEO Dario Amodei during an IPO-related video.

Eli Lilly CEO and Experts Criticize Anthropic Chief Over Medical Claims🚀Startups & Funding

Photo: Hacker News Front Page

Key points

  • Eli Lilly CEO Dave Ricks publicly critiqued timeline claims made by Anthropic CEO Dario Amodei.
  • Medical researchers argued that clinical trials cannot be sped up to match the stated AI projections.
  • Critics compared the controversial statements to past corporate overpromises in the biotech sector.

Medical and tech experts, alongside Eli Lilly Chairman and CEO Dave Ricks, have heavily criticized statements made by Anthropic CEO Dario Amodei regarding rapid advancements in medicine. The remarks, tied to a video presentation around an initial public offering, included ambitious timelines for eradicating cancer and curing mental illness that industry specialists have deemed unrealistic.

Critics from the medical and research communities pointed out that clinical trials cannot be artificially expedited to match the projections outlined by Amodei. Observers compared the overpromises to past industry controversies, arguing that current biotechnology and software capabilities are not positioned to achieve such sweeping health breakthroughs on the suggested schedule.

What to watch next: Monitor how public statements from AI executives affect investor sentiment and regulatory scrutiny during upcoming tech offerings.

Source Hacker News Front Page — garymarcus.substack.com/p/breaking-eli-lilly-ceo-becomes-latest ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.